ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?

• click to rate

  Posted by Two Blokes Jul 11 - Filed in Stock - 8 views
  
  AbbVie edges ahead of Bristol Myers with strong Skyrizi and Rinvoq growth, offsetting Humira declines and portfolio headwinds.